IRCT20170513033941N62
Completed
Phase 3
Investigation of the effect of selenium supplementation on gene expression levels associated with insulin, lipid and inflammatory metabolism in diabetic hemodialysis patients
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Islamic Azad University
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diabetic hemodialysis patients aged 45 to 75 years.
Exclusion Criteria
- •Patients taking antioxidant and/or anti\-inflammatory supplements within 3 months prior to intervention
- •Patients with infectious diseases
- •Patients with malignant diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
effect of selenium in systemic lupus erythematosusIRCT20210717051914N2Ahvaz University of Medical Sciences56
Recruiting
Phase 2
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0IRCT20201129049534N6Esfahan University of Medical Sciences60
Recruiting
Phase 2
Evaluation of the efficacy of Selenium supplementation therapy on the inflammatory markers oxidative stress and liver functional parametersIRCT20210326050772N1Zanjan University of Medical Sciences40
Completed
Phase 3
Effect of selenium on malnutrition- inflamation complex syndrome (MICS) in hemodialysis patientsEnd stage renal disease , hemodialysis.Chronic renal failureIRCT138812043408N1Shiraz University of Medical Sciences80
Completed
Phase 2
Determining the effect of selenium supplement on inflammatory, oxidative and nutritional markers in hemodialysis patients in shiraz medical university hemodialysis centersEnd stage renal disease.End-stage renal diseaseIRCT138812083446N1Shiraz university of medical sciences80